Full-Time

Associate Director

US Oncology Promotion Digital Engagement, Precision Medicine

Posted on 4/8/2025

Merck

Merck

10,001+ employees

Develops medicines and vaccines for health issues

No salary listed

Senior

No H1B Sponsorship

North Wales, PA, USA

Hybrid work model requires three days on-site per week, Monday - Thursday, with Friday designated as a remote-working day.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Agile
Branding/Brand Strategy
Social Media
Marketing
Data Analysis
Requirements
  • Minimum of 4 years’ experience in marketing, marketing communications, or marketing support.
  • Demonstrated ability to execute a brand or customer marketing strategy.
  • Experience and success in cross-functional leadership and teamwork.
  • Strong knowledge of marketing principles.
  • Campaign and Message development experience.
  • Excellent planning and presentation skills.
  • Strong communication skills.
  • Agency/vendor management skills.
Responsibilities
  • Leading the development, measurement, and optimization of digital campaigns to support marketing strategy.
  • Knowing the customer: a deep understanding of customer segments, needs, channel preferences and profitability/life-time value.
  • Leading the development of HCP marketing materials and digital assets, inclusive of online video, emails, display/banner ads, alerts, web content, media/paid search content optimization, social media, point-of-care assets, print, and disease awareness assets.
  • Shaping the key strategic communication objective choices for assigned tumor(s) ensuring all tactics align to the customer experience plan and achieve desired customer experience.
  • Knowing the business: behavioral, and communications objectives and prioritizing the development of assets using insights and digital knowledge, including customer experience best practices, and targeting.
  • Working in an agile mindset (addressing ambiguity, working comfortably outside of existing processes or structures, establishing networks across stakeholders to drive influence and alignment, testing, and learning to drive a culture of innovation, focusing on the customer experience, committing to applying agile values and principles).
  • Partnering with the US marketing team in the annual Integrated Profit Plan (IPP) process and contributing to the development of the brand building tools (L3).
  • Working collaboratively with multiple internal teams including Marketing, Channel Strategy and Engagement (CSE), Market Research, Analytics, and Operations.
  • Managing the day-to-day interactions with the agency partner(s) and other outsourced vendors; leading the creation and monitoring of agency digital scopes of work (SOW) and participating in the bi-annual agency evaluation process.
  • Managing applicable budgets.
  • Evaluating the revalidation of marketing and digital assets.
  • Implementing Safety Label Updates (SLUs) on promotional assets and ensuring compliance with Subpart E regulations, when applicable.
  • Demonstrating our company's Ways of Working principles and enterprise leadership skills.
  • Conducting all activities in full compliance with our company policies, values, and standards.
Desired Qualifications
  • Experience in US HCP marketing, HCP marketing communications, or US HCP marketing support of pharmaceutical products.
  • Knowledge/experience with the Oncology Marketplace.
  • Product launch or launch planning experience.
  • Market research experience.
  • Knowledge of Company commercial, regulatory, and legal compliance policies.
  • Experience in the end-to-end Medical/Legal (Promotion Review Team) review and delivery process.
  • Veeva/PromoMats experience.

Merck develops medicines and vaccines to address significant health challenges such as cardiovascular disease, diabetes, and cancer. The company conducts extensive research and development to create new treatments, focusing on the pharmaceutical and biotechnology sectors. Merck generates revenue through the sale of prescription medications, vaccines, and animal health products. A key aspect of Merck's approach is its commitment to patient assistance programs, which provide free medicines and vaccines to eligible patients. Additionally, Merck supports healthcare professionals with resources like Merck Connect and Merck Manuals, distinguishing itself from competitors by its comprehensive support for both patients and healthcare providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kenilworth, Illinois

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • Positive Phase 3 results for pembrolizumab suggest new cancer treatment opportunities.
  • Kinase inhibitors' use in autoimmune diseases offers Merck portfolio diversification.
  • Merck's digital health innovation leadership strengthens its competitive position.

What critics are saying

  • Data privacy concerns may arise from AI integration in healthcare settings.
  • Oral peptide delivery faces scientific and regulatory challenges.
  • Intensifying competition from companies like Novartis may impact Merck's market share.

What makes Merck unique

  • Merck's collaboration with Microsoft enhances clinical workflows using AI in healthcare.
  • The Cyprumed deal aims to make peptide drugs orally available, improving patient experience.
  • Merck's investment in vaccine manufacturing aligns with rising global vaccine demand.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Holidays

Paid Vacation

Paid Sick Leave

Hybrid Work Options

Flexible Work Hours

Company News

Healthcare Dive
Apr 16th, 2025
Merck Manuals Integrates Medical Reference Within Microsoft Copilot Studio

This collaboration exemplifies a commitment to enhancing clinical workflows by incorporating Merck Manuals' authoritative content into Microsoft's healthcare agent service in Copilot Studio.

Sandra Gona
Apr 16th, 2025
India logs 2,430 new Covid cases_Spider information

As a result of these efforts, Merck has been recognized as a "Digital Health Innovation Leader" for two consecutive years since 2023.

BioSpace
Apr 15th, 2025
Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M

Merck on Tuesday entered into a nonexclusive licensing and option pact with Austrian biotech Cyprumed in a bid to make its peptide drugs orally available.

PR Newswire
Apr 14th, 2025
Merck Manuals To Collaborate With Microsoft To Integrate Medical Information Resources Into Healthcare Agent Service In Microsoft Copilot Studio

RAHWAY, N.J., April 14, 2025 /PRNewswire/ -- The Merck Manuals is pleased to announce its collaboration with Microsoft to integrate its esteemed professional medical reference into healthcare agent service in Microsoft Copilot Studio. This exciting initiative harnesses the power of Generative AI (GenAI) to provide clinicians with trusted, comprehensive, and evidence-based medical content at the point of care.The Merck Manuals is proud to be an independent (non-government) medical information resource integrated into this platform. This collaboration exemplifies a commitment to enhancing clinical workflows by incorporating Merck Manuals' authoritative content into Microsoft's healthcare agent service in Copilot Studio. This integration empowers healthcare technology developers to create generative AI-driven healthcare agents that leverage this high-value content to grant clinicians immediate access to vital medical information."Clinicians and healthcare organizations worldwide depend on the Merck Manuals and MSD Manuals for accurate and reliable answers to their clinical questions," stated Dr. Sandy Falk, Editor-in-Chief of the Merck Manuals. "Through this collaboration with Microsoft, we are building solutions to deliver our comprehensive, evidence-based content to meet the needs of healthcare professionals

APP
Apr 14th, 2025
Novartis plans $23B expansion of manufacturing in US, including North Jersey site

Merck announced plans to spend $1 billion on a vaccine manufacturing site in North Carolina, plus $8 billion on other upgrades.

INACTIVE